Fusion Pharmaceuticals
Based in Hamilton, ON & Boston, MA, Fusion is developing next-generation radiopharmaceuticals for precision oncology.
Hamilton, Canada
124 employees
Post Ipo Equity
Total: $237.00M
Biopharma, Biotechnology +1
General Information
Get notified when Fusion Pharmaceuticals moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Fusion Pharmaceuticals
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Canada Market
Biopharma
About Fusion Pharmaceuticals
Taxonomy: Oncology, Radiopharmaceuticals, Precision Medicine, Clinical-Stage, Alpha Particle Therapy, Fast-Clear Linker Technology, Tumor Targeting, Isotope Therapy, Cancer Treatment, Clinical Trials, Hamilton, ON, Boston, MA, Pharmaceutical Development, Precision Oncology
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | •••••• | 5 |
|
13 Feb 2023 |
| Venture Round | •••••• | 1 | •••• •••• | 13 Jan 2020 |
| Series B | •••••• | 4 |
|
01 Apr 2019 |
| Series A | •••••• | - | 25 Sep 2017 | |
| Series A | •••••• | - | 23 Feb 2017 |
Latest News
View All
Fusion Pharmaceuticals Alternatives & Competitors
Revolutionary Alpha Emitters Radiotherapy
Changing the way cancer is diagnosed and treated
Innovations for better cancer care
FAQ About Fusion Pharmaceuticals
Don't just browse. Track.
Signal Tracker monitors Fusion Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
